Belite Bio Inc

BLTE | NASDAQ

Price Alert Chart Builder DCF Calculator

$176.43

+$3.03 (+1.75%)

Sep 22, 2026, 10:51 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

TTM Period Ending	Q2 2026 Jun 29, 2026	Q1 2026 Mar 30, 2026	Q4 2025 Dec 30, 2025	Q3 2025 Sep 29, 2025	Q2 2025 Jun 29, 2025	Q1 2025 Mar 30, 2025	Q4 2024 Dec 30, 2024	Q3 2024 Sep 29, 2024	Q2 2024 May 30, 2024	Q1 2024 Mar 30, 2024	Q4 2023 Dec 30, 2023	Q3 2023 Sep 29, 2023	Q2 2023 Jun 29, 2023	Q1 2023 Mar 30, 2023	Q4 2022 Dec 30, 2022	Q3 2022 Sep 29, 2022	Q2 2022 Jun 29, 2022	Q1 2022 Mar 30, 2022	Q4 2021 Dec 30, 2021	Q3 2021 Sep 29, 2021	Q2 2021 Jun 29, 2021	Q1 2021 Mar 30, 2021
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-118.69M	-101.38M	-84.21M	-67.59M	-54.31M	-47.19M	-40M	-35.49M	-36.72M	-33.12M	-31.67M	-31.43M	-23.01M	-18.65M	-12.82M	-8.6M	-8.56M	-8.45M	-9.8M	-9.11M	-8.43M	-7.09M
Interest Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	3.50	3.50	3.50	3.50	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-102.31M	-90.27M	-77.61M	-62.39M	-49.38M	-42.55M	-36.14M	-33.03M	-35.28M	-32.6M	-31.62M	-31.42M	-22.89M	-18.47M	-12.65M	-8.34M	-8.41M	-8.38M	-9.67M	-9.01M	-8.36M	-7.06M
Net Income	-102.36M	-90.27M	-77.61M	-62.39M	-49.38M	-42.55M	-36.14M	-33.03M	-35.29M	-32.61M	-31.63M	-31.43M	-22.89M	-18.47M	-12.65M	-8.34M	-8.41M	-8.38M	-9.67M	-9.01M	-8.36M	-7.06M
Selling & General & Admin	59.88M	49.73M	38.83M	29.58M	19.77M	14.62M	10.06M	7.95M	7.27M	7.23M	6.82M	6.23M	5.36M	4.94M	3.95M	3.07M	2.32M	1.97M	2.38M	2.2M	2.02M	2.04M
Research & Development	58.81M	51.64M	45.38M	38.01M	34.54M	32.57M	29.94M	27.55M	29.45M	25.89M	24.84M	25.21M	17.65M	13.71M	8.87M	5.53M	6.24M	6.48M	7.42M	6.91M	6.41M	5.05M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	118.69M	101.38M	84.21M	67.59M	54.31M	47.19M	40M	35.49M	36.72M	33.12M	31.67M	31.43M	23.01M	18.65M	12.82M	8.6M	8.56M	8.45M	9.8M	9.11M	8.43M	7.09M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	32.75K	32.75K	32.75K	32.75K	500	500	500	500	5.25K	10.5K	15.75K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	118.69M	101.38M	84.21M	67.59M	54.31M	47.19M	40M	35.49M	36.72M	33.12M	31.67M	31.43M	23.01M	18.65M	12.82M	8.6M	8.56M	8.45M	9.8M	9.11M	8.43M	7.09M
Income Tax Expense	55K	n/a	n/a	n/a	n/a	n/a	6K	5K	6K	9K	9K	10K	9K	6K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	500
Shares Outstanding (Basic)	40.18M	39.87M	33.54M	33.22M	32.59M	32.08M	31.45M	30.69M	30.32M	29.68M	28.32M	27.32M	25.79M	20.95M	22.42M	24.87M	19.66M	24.1M	9.57M	9.57M	9.57M	9.57M
Shares Outstanding (Diluted)	40.18M	39.87M	33.54M	33.22M	32.59M	32.08M	31.45M	30.69M	30.32M	29.68M	28.32M	27.32M	25.79M	20.95M	22.42M	24.87M	19.66M	24.1M	9.57M	9.57M	9.57M	9.57M
EPS (Basic)	-2.76	-2.55	-2.31	-1.91	-1.54	-1.35	-1.18	-1.11	-1.23	-1.18	-1.24	-1.29	-0.99	-0.85	-0.56	-0.52	-0.68	-0.81	-1.02	-0.97	-0.92	-0.79
EPS (Diluted)	-2.76	-2.55	-2.31	-1.91	-1.54	-1.35	-1.18	-1.11	-1.23	-1.18	-1.24	-1.29	-0.99	-0.85	-0.56	-0.52	-0.68	-0.81	-1.02	-0.97	-0.92	-0.79
EBITDA	-114.22M	-95.59M	-82.88M	-59.78M	-46.74M	-39.92M	-33.51M	-32.82M	-35.09M	-32.44M	-31.5M	-31.15M	-22.63M	-18.22M	-12.4M	-8.33M	-8.39M	-8.35M	-9.67M	-9.02M	-8.37M	-7.07M
EBIT	-114.22M	-95.63M	-82.97M	-59.87M	-46.86M	-40.03M	-33.62M	-32.92M	-35.18M	-32.49M	-31.52M	-31.16M	-22.63M	-18.22M	-12.4M	-8.34M	-8.41M	-8.38M	-9.7M	-9.05M	-8.39M	-7.09M
Depreciation & Amortization	117	42.12K	84.12K	84K	118.75K	111.5K	104.25K	104.25K	85.5K	50.75K	16K	16K	n/a	n/a	n/a	7.5K	15K	22.5K	30K	27K	24K	20.5K